For Retinoblastoma, Testing Packaged CAR T Cells - National Cancer Institute
For children with the eye cancer retinoblastoma, researchers are studying a CAR T-cell therapy in which the engineered immune cells are packaged in a biodegradable material called a hydrogel and then injected directly into tumors. The treatment showed promise when tested in mice.